The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects

Diabetes

Volumn 46, Issue 12, 1997, Pages 1990-1995

  Mykkänen, Leena ^a,d   Haffner, Steven M ^a   Hales, C Nick ^b   Rönnemaa, Tapani ^c   Laakso, Markku ^d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0030781055     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.12.1990     Document Type: Article

References (37)

1. Melani F, Rubenstein AH, Steiner DF: Human serum proinsulin. J Clin Invest 49:497-507,1970
2. Tillil H, Frank BH, Pekar AH, Broelsch C, Rubenstein AH, Polonsky KS: Hypoglycemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolites. Endocrinology 127:2418-2422, 1990
3. Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Bowsher RR, Anderson JH: Biosynthetic human proinsulin: review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience. Diabetes Care 5:666-692, 1992
4. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr Disproportionate elevation of immunoreactive proinsulin in Type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30:698-702, 1987
5. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y: Serum proinsulin levels at fasting and after oral glucose load in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 31:355-360, 1988
6. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN: Insulin deficiency in non-insulin-dependent diabetes. Lancet i:293-295, 1989
7. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PH, Porte D Jr Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 70:1247-1253, 1990
8. Reaven GM, Chen Y-DI, Hollenbeck CB, Sheu WHH, Ostrega D, Polonsky KS: Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 76:44-48, 1993
9. Birkeland KI, Torjesen PA, Erikson J, Vaaler S, Groop L: Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemia. Diabetes Care 17:1307-1310, 1994
10. Davies MJ, Rayman G, Gray IP, Day JL, Hales CN: Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 10:313-320, 1993
11. Haffner SM, Stern MP, Miettinen H, Gingerich R, Bowsher RR: Higher proinsulin and specific insulin are both associated with a parental history of diabetes in nondiabetic Mexican-American subjects. Diabetes 44:1156-1160, 1995
12. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY: Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes 44:173-179, 1995
13. Mykkänen L, Haffner SM, Kuusisto J, Pyörälä K, Hales CN, Laakso M: Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 38:1176-1182, 1995
14. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ: Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study. Diabetologia 39:113-118, 1996
15. Beer SF, O'Rahilly S, Spivey RS, Hales CN, Turner RC: Plasma proinsulin in first-degree relatives of type 2 diabetic subjects. Diabetes Res 14:51-54,1990
16. Hales CN, Byrne CD, Petry CJ, Wareham NJ: Measurement of insulin and proinsulin. Diabetes Rev 4:320-335, 1996
17. Kahn SE, McCulloch DK, Schwartz MW, Palmer JP, Porte D Jr: Effect of insulin resistance and hyperglycemia on proinsulin release in a primate model of diabetes mellitus. J Clin Endocrinol Metab 74:192-197, 1992.
18. Phillips DIW, Clark PM, Hales CN, Osmond C: Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11:286-292, 1994
19. Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I: Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care 11:449-463, 1988
20. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
21. Mykkänen L, Haffner SM, Rönnemaa T, Bergman R, Leino A, Laakso M: Is there a sex difference in the association of plasma insulin level and insulin sensitivity with serum lipids and lipoproteins? Metabolism 43:523-528, 1994
22. Welch S, Gebhart SS, Bergman RN, Phillips LS: Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 71:1508-1518,1990
23. Steil GM, Volund A, Kahn SE, Bergman RN: Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model: suitability for use in population studies. Diabetes 42:250-256, 1993
24. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-E677, 1979
25. Bergman R, Prager R, VØlund A, Olefsky JM: Equivalence of the insulin sensitivity index derived by the minimal model and the euglycemic calmp. J Clin Invest 79:790-800, 1987
26. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YD, Sands RE, Pei D, Savage PJ, Bergman RN: A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114-1121, 1994
27. Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B, Gingerich R, Goldstein D, Widemeyer H-M, Haffner S, Hales CN, Jarett L, Polonsky K, Porte D, Skyler J, Webb G, Gallagher K: Task Force Report: Report of the American Diabetes Association's Task Force on Standardization of the Insulin Assay. Diabetes 45:242-256, 1996
28. Hales CN, Handle PJ: Immunoassay of insulin with antibody precipitate. Biochem J 88:137-146, 1963
29. Sobey WJ, Beer SF, Carrington CA, Clark PM, Frank BH, Gray IP, Luzio SD, Owens DR, Schneider AE, Siddle K, Temple RC, Hales CN: Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32,33 split proinsulins. Biochem J 260:535-541, 1989
30. Ostrega D, Polonsky K, Nagi D, Yudkin J, Cox LJ, Clark PMS, Hales CN: Measurement of proinsulin and intermediates: validation of immunoassay methods by high-performance liquid chromatography. Diabetes 44:437-440,1995
31. Proudler AJ, Godsland IF, Stevenson JC: Insulin propeptides in conditions associated with insulin resistance in humans and their relevance to insulin measurements. Metabolism 43:446-449, 1994
32. Shiraishi I, Iwamoto Y, Kuzuya T, Matsuda A, Kumakura S: Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance. Diabetologia 34:737-741, 1991
33. Haffner SM, Mykkänen L, Valdez RA, Stern MP, Holloway DL, Monterrosa A, Bowsher RR: Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J Clin Endocrinol Metab 79:1806-1810, 1994
34. Billaudel B, Sutter B: Direct effect of corticosterone upon insulin secretion studies by three different techniques. Horm Metab Res 11:555-560, 1979
35. Nagamatsu S. Bolaffi JL, Grodsky GM: Direct effects of glucose on proinsulin synthesis and processing during desensitization. Endocrinology 120:1225-1231, 1987
36. Martin SK, Carroll R, Benig M, Steiner DF: Regulation by glucose of the biosynthesis of PC2, PC3 and proinsulin in (ob/ob) mouse islet of Langerhans. FEBS Lett 356:279-282, 1994
37. Porte D Jr, Kahn SE: Hyperproinsulinemia and amyloid in NIDDM: clues to etiology of islet β-cell dysfunction. Diabetes 38:1333-1336,1989